Bender Bruce G, Rankin Allison, Tran Zung Vu, Wamboldt Frederick S
Department of Pediatrics, National Jewish Health, Denver, Colorado 80206, USA.
Ann Allergy Asthma Immunol. 2008 Oct;101(4):382-6. doi: 10.1016/S1081-1206(10)60314-6.
Although it is known that most patients do not consistently take controller medications every day, the impact of nonadherence on asthma control is not well documented.
To establish the relationship between medication adherence and symptom control in adolescents and young adults with asthma.
A total of 756 adolescents and young adults diagnosed as having mild to moderate asthma on entry into the original study underwent 6 monthly telephone interviews as an ancillary project to the Childhood Asthma Management Program Continuation Study. Participants were queried about medication use and symptom control within each 1-month interview window. Strategies adopted to improve self-report accuracy included use of repeated interviews, confidential reporting to staff unknown to the participants, and use of questions focused on recent behavior.
Only participants who were consistently on inhaled corticosteroids (ICSs) for the entire 6-month study interval were included. Three groups of patients were contrasted: those not on ICSs (n = 420), those on ICSs with high adherence (> or = 75% of medication taken, n = 90), and those on ICSs with low/medium adherence (< 75% of medication taken, n = 148). Participants in the low/medium adherence group reported, on average, less symptom control and more variability in wheezing, awakening at night, missed activities, and beta2-agonist use during the 6-month period, although most in this group perceived their asthma to be under good control.
Despite extensive patient education and support, diminished ICS adherence was frequent and undermined symptom control in this group of adolescents and young adults with mild to moderate asthma.
尽管已知大多数患者并非每天都持续服用控制药物,但药物不依从对哮喘控制的影响尚无充分记录。
确定青少年和青年哮喘患者的药物依从性与症状控制之间的关系。
共有756名在最初研究中被诊断为轻度至中度哮喘的青少年和青年作为儿童哮喘管理项目延续研究的辅助项目,接受了6次每月一次的电话访谈。在每次1个月的访谈窗口内,询问参与者的用药情况和症状控制情况。为提高自我报告准确性所采用的策略包括进行重复访谈、向参与者不认识的工作人员进行保密报告以及使用关注近期行为的问题。
仅纳入在整个6个月研究期间持续使用吸入性糖皮质激素(ICS)的参与者。对比了三组患者:未使用ICS的患者(n = 420)、高依从性使用ICS的患者(服用药物的≥75%,n = 90)和低/中等依从性使用ICS的患者(服用药物的<75%,n = 148)。低/中等依从性组的参与者在6个月期间平均报告症状控制较差,喘息、夜间觉醒、错过活动和使用β2激动剂的变异性更大,尽管该组中的大多数人认为他们的哮喘得到了良好控制。
尽管进行了广泛的患者教育和支持,但在这组轻度至中度哮喘的青少年和青年中,ICS依从性降低的情况频繁发生,并破坏了症状控制。